Quanta™ to Present Highly Anticipated Real-World Evidence at the American Society of Nephrology (ASN) Kidney Week 2023
Quanta Dialysis Technologies, a medical technology company committed to making kidney care more accessible with its Quanta™ Dialysis System, today announced the presentation of real-world evidence from its Home Run™ study at the American Society of Nephrology (ASN) Kidney Week…
AEYE Health and Topcon Screen Announce Partnership to Enhance Point-of-Care Diabetic Retinopathy Screening with Best-in-Class AI Technology
AEYE Health, the leader in artificial intelligence-based diagnostics for retinal imaging, and Topcon Screen, a leader in point-of-care diabetic eye exams, today announced a partnership to deliver point-of-care screening for diabetic retinopathy that uses AI to produce immediate and accurate results….
Seelos Therapeutics to Present a Poster on SLS-005 in Alzheimer’s Disease at Neuroscience 2023
Seelos Therapeutics, Inc. (Nasdaq: SEEL) (“Seelos”), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases, today announced that it has been selected to present a poster from a study of SLS-005 (trehalose…
New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy USA – English 
Calliditas Therapeutics AB (Nasdaq: CALT) (Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that its commercial partner Everest Medicines (HKEX 1952.HK) (“Everest”) received approval from the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China. The approval for Nefecon is for the treatment of primary immunoglobulin…
Henlius Deepens Collaboration with Intas to bring Henlius’ Novel anti-PD-1 mAb Serplulimab to Europe and India
Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with Intas Pharmaceuticals Limited (“Intas”) for the development and commercialisation in Europe and India for several indications including ES-SCLC, and specific formulation of HANSIZHUANG (serplulimab injection), Henlius’ novel anti-PD-1 mAb. In June 2018,…
Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy
Everest Medicines (HKEX 1952.HK, “Everest,” or the “Company”), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration Bureau of the Macau Special Administrative Region, China, has approved its New Drug…
GC AESTHETICS AND BIMINI HEALTH TECH FORM STRATEGIC PARTNERSHIP TO ADVANCE BREAST RECONSTRUCTION SOLUTIONS GLOBALLY
GC Aesthetics®, a long-established brand in breast aesthetics, and Bimini Health Tech (“Bimini”), a pioneer in novel healthcare solutions, are pleased to announce their groundbreaking Joint Venture partnership aimed at revolutionizing breast reconstruction worldwide. This strategic collaboration combines GC Aesthetics’ 40…
Cohen Veterans Network Releases Findings of Suicide Risk Stratification Study: Measurement-Based Care and Collaboration Critical to Suicide Prevention Ecosystem
Today, Cohen Veterans Network (CVN), a not-for-profit philanthropic organization that serves post-9/11 veterans, service members and military families through a nationwide system of mental health clinics, released findings from its study on clinical decision-making in suicide risk assessment. The network simultaneously launched…
REGENATIVE LABS, TOGETHER WITH THE PAIN AND SLEEP THERAPY CENTER, PUBLISHES CASE STUDY DEMONSTRATING NEW CARE ADVANCEMENTS USING WHARTON’S JELLY ALLOGRAFTS IN TEMPOROMANDIBULAR JOINT DEFECTS
Regenative Labs (Regenative), a leading HCT/P manufacturer, announces the publication of a case study demonstrating new care advancements using its Wharton’s Jelly allografts in the supplementation of Temporomandibular Joint (TMJ) defects. The case study titled “Single-Center Retrospective Study of Flowable Umbilical…
Telehealth resources for eating disorders practitioners increases
The International Association of Eating Disorders Professionals (iaedp™) is supporting telehealth practitioners and professionals in the eating disorder field. Telehealth saw a boom during the pandemic; the concept and practice were already in place well but is now a common occurrence. Rapidly,…
